A phase II trial of high-dose gemcitabine (GEM) plus cisplatin (CDDP) in advanced non small cell lung cancer(NSCLC).: Preliminary results.

被引：0
|
作者：
Isla, D [1 ]
Mayordom, JI [1 ]
Yubero, A [1 ]
Cajal, R [1 ]
Bueso, P [1 ]
Herráez, J [1 ]
Martí, JL [1 ]
Murillo, L [1 ]
Sáenz, A [1 ]
Escudero, P [1 ]
García-Prats, MD [1 ]
Tres, A [1 ]
机构：
[1] Univ Zaragoza, Div Med Oncol, Clin Hosp, Zaragoza, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] Phase II study with high-dose gemcitabine (GEM) plus cisplatin (CDDP) in advanced non-small-cell lung cancer (NSCLC).
    Tres, A
    Isla, D
    Mayordomo, JI
    Escudero, P
    Sáenz, A
    Bueso, P
    Herráez, J
    Marti, JL
    Murillo, L
    Filipovich, E
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [2] Gemcitabine (G) plus cisplatin (C) in advanced non-small cell lung cancer (NSCLC): Final phase II results.
    Casal, J
    Huidobro, G
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
  • [3] Gemcitabine (GEM) Cisplatin (CDDP) Vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized study
    Comella, P
    Panza, N
    Frasci, G
    Pacillo, C
    Nicolella, GP
    Natale, M
    DeCataldis, G
    Manzione, L
    Bilancia, D
    Cioffi, R
    Micillo, E
    Maiorino, L
    Lorusso, V
    Ianniello, GP
    DellaVittoria, M
    Piantedosi, F
    Perchard, J
    Comella, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1037 - 1037
  • [4] A phase II study with cisplatin (cddp) and gemcitabine (gem) in elderly patients with advanced non-small cell lung cancer
    Buffoni, L.
    Dongiovanni, D.
    Barone, C.
    Larovere, E.
    Grillo, R.
    Gaspari, F.
    Schena, M.
    Fissore, C.
    Addeo, A.
    Ciuffreda, L.
    EJC SUPPLEMENTS, 2007, 5 (04): : 176 - 177
  • [5] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [6] Gemcitabine plus cisplatin in advanced non small cell lung cancer (NSCLC)
    Casal, J
    Huidobro, G
    Grande, C
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [7] Phase I study of low-dose cisplatin (CDDP) and gemcitabine (GEM) chemotherapy for elderly patients with advanced non-small cell lung cancer (NSCLC)
    Buffoni, L.
    Dongiovanni, D.
    Barone, C.
    Fissore, C.
    Larovere, E.
    Grillo, R.
    Salvadori, A.
    Birocco, N.
    Ciuffreda, L.
    Bertetto, O.
    Schena, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI21 - XI22
  • [8] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Valerie Israel
    Scott T. Tagawa
    Terry Snyder
    Susan Jeffers
    Derek Raghavan
    Investigational New Drugs, 2004, 22 : 291 - 297
  • [9] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Israel, V
    Tagawa, ST
    Snyder, T
    Jeffers, S
    Raghavan, D
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) : 291 - 297
  • [10] A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC)
    Saito, J
    Nakai, Y
    Saijo, Y
    Nukiwa, T
    Koinumaru, S
    Matsuura, Y
    Aso, N
    Yamane, Y
    Tsukamoto, T
    Sayama, T
    Nakabayashi, T
    LUNG CANCER, 2001, 31 (2-3) : 285 - 293
12345